Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

297 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Provir/Latitude 45 study: A step towards a multi-epitopic CTL vaccine designed on archived HIV-1 DNA and according to dominant HLA I alleles.
Tumiotto C, Alves BM, Recordon-Pinson P, Jourdain M, Bellecave P, Guidicelli GL, Visentin J, Bonnet F, Hessamfar M, Neau D, Sanchez J, Brander C, Sajadi M, Eyzaguirre L, Soares EA, Routy JP, Soares MA, Fleury H. Tumiotto C, et al. Among authors: brander c. PLoS One. 2019 Feb 27;14(2):e0212347. doi: 10.1371/journal.pone.0212347. eCollection 2019. PLoS One. 2019. PMID: 30811489 Free PMC article.
Relative dominance of Gag p24-specific cytotoxic T lymphocytes is associated with human immunodeficiency virus control.
Zuñiga R, Lucchetti A, Galvan P, Sanchez S, Sanchez C, Hernandez A, Sanchez H, Frahm N, Linde CH, Hewitt HS, Hildebrand W, Altfeld M, Allen TM, Walker BD, Korber BT, Leitner T, Sanchez J, Brander C. Zuñiga R, et al. Among authors: brander c. J Virol. 2006 Mar;80(6):3122-5. doi: 10.1128/JVI.80.6.3122-3125.2006. J Virol. 2006. PMID: 16501126 Free PMC article.
Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1.
Martinez-Picado J, Prado JG, Fry EE, Pfafferott K, Leslie A, Chetty S, Thobakgale C, Honeyborne I, Crawford H, Matthews P, Pillay T, Rousseau C, Mullins JI, Brander C, Walker BD, Stuart DI, Kiepiela P, Goulder P. Martinez-Picado J, et al. Among authors: brander c. J Virol. 2006 Apr;80(7):3617-23. doi: 10.1128/JVI.80.7.3617-3623.2006. J Virol. 2006. PMID: 16537629 Free PMC article.
Amino-acid co-variation in HIV-1 Gag subtype C: HLA-mediated selection pressure and compensatory dynamics.
Rolland M, Carlson JM, Manocheewa S, Swain JV, Lanxon-Cookson E, Deng W, Rousseau CM, Raugi DN, Learn GH, Maust BS, Coovadia H, Ndung'u T, Goulder PJ, Walker BD, Brander C, Heckerman DE, Mullins JI. Rolland M, et al. Among authors: brander c. PLoS One. 2010 Sep 1;5(9):e12463. doi: 10.1371/journal.pone.0012463. PLoS One. 2010. PMID: 20824187 Free PMC article.
Receptor-ligand requirements for increased NK cell polyfunctional potential in slow progressors infected with HIV-1 coexpressing KIR3DL1*h/*y and HLA-B*57.
Kamya P, Boulet S, Tsoukas CM, Routy JP, Thomas R, Côté P, Boulassel MR, Baril JG, Kovacs C, Migueles SA, Connors M, Suscovich TJ, Brander C, Tremblay CL, Bernard N; Canadian Cohort of HIV Infected Slow Progressors. Kamya P, et al. Among authors: brander c. J Virol. 2011 Jun;85(12):5949-60. doi: 10.1128/JVI.02652-10. Epub 2011 Apr 6. J Virol. 2011. PMID: 21471235 Free PMC article.
High-functional-avidity cytotoxic T lymphocyte responses to HLA-B-restricted Gag-derived epitopes associated with relative HIV control.
Berger CT, Frahm N, Price DA, Mothe B, Ghebremichael M, Hartman KL, Henry LM, Brenchley JM, Ruff LE, Venturi V, Pereyra F, Sidney J, Sette A, Douek DC, Walker BD, Kaufmann DE, Brander C. Berger CT, et al. Among authors: brander c. J Virol. 2011 Sep;85(18):9334-45. doi: 10.1128/JVI.00460-11. Epub 2011 Jul 13. J Virol. 2011. PMID: 21752903 Free PMC article.
Immune correlates of HIV control.
Prado JG, Carrillo J, Blanco-Heredia J, Brander C. Prado JG, et al. Among authors: brander c. Curr Med Chem. 2011;18(26):3963-70. doi: 10.2174/092986711796957202. Curr Med Chem. 2011. PMID: 21824095 Review.
Definition of the viral targets of protective HIV-1-specific T cell responses.
Mothe B, Llano A, Ibarrondo J, Daniels M, Miranda C, Zamarreño J, Bach V, Zuniga R, Pérez-Álvarez S, Berger CT, Puertas MC, Martinez-Picado J, Rolland M, Farfan M, Szinger JJ, Hildebrand WH, Yang OO, Sanchez-Merino V, Brumme CJ, Brumme ZL, Heckerman D, Allen TM, Mullins JI, Gómez G, Goulder PJ, Walker BD, Gatell JM, Clotet B, Korber BT, Sanchez J, Brander C. Mothe B, et al. Among authors: brander c. J Transl Med. 2011 Dec 7;9:208. doi: 10.1186/1479-5876-9-208. J Transl Med. 2011. PMID: 22152067 Free PMC article.
CTL responses of high functional avidity and broad variant cross-reactivity are associated with HIV control.
Mothe B, Llano A, Ibarrondo J, Zamarreño J, Schiaulini M, Miranda C, Ruiz-Riol M, Berger CT, Herrero MJ, Palou E, Plana M, Rolland M, Khatri A, Heckerman D, Pereyra F, Walker BD, Weiner D, Paredes R, Clotet B, Felber BK, Pavlakis GN, Mullins JI, Brander C. Mothe B, et al. Among authors: brander c. PLoS One. 2012;7(1):e29717. doi: 10.1371/journal.pone.0029717. Epub 2012 Jan 4. PLoS One. 2012. PMID: 22238642 Free PMC article.
297 results